

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.42242130 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.42242130 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.98608950 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 5.77361462 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.80038076 |
| 6 | viral transcription (GO:0019083) | 4.56621407 |
| 7 | translational termination (GO:0006415) | 4.36168979 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.20505046 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.11999902 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.11999902 |
| 11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.96158698 |
| 12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.83142170 |
| 13 | translational elongation (GO:0006414) | 3.82007289 |
| 14 | cytidine deamination (GO:0009972) | 3.80747967 |
| 15 | cytidine metabolic process (GO:0046087) | 3.80747967 |
| 16 | cytidine catabolic process (GO:0006216) | 3.80747967 |
| 17 | response to interferon-beta (GO:0035456) | 3.80299799 |
| 18 | ribosomal small subunit biogenesis (GO:0042274) | 3.77724605 |
| 19 | DNA deamination (GO:0045006) | 3.76495853 |
| 20 | protein targeting to ER (GO:0045047) | 3.71662243 |
| 21 | cotranslational protein targeting to membrane (GO:0006613) | 3.70857108 |
| 22 | response to type I interferon (GO:0034340) | 3.66879104 |
| 23 | cellular response to type I interferon (GO:0071357) | 3.66074725 |
| 24 | type I interferon signaling pathway (GO:0060337) | 3.66074725 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62783419 |
| 26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.58150712 |
| 27 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.55504932 |
| 28 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.54698337 |
| 29 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.51935265 |
| 30 | protein localization to endoplasmic reticulum (GO:0070972) | 3.51730098 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.50780179 |
| 32 | immunoglobulin mediated immune response (GO:0016064) | 3.43901448 |
| 33 | viral life cycle (GO:0019058) | 3.41259251 |
| 34 | cellular response to interferon-beta (GO:0035458) | 3.32742770 |
| 35 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.32286243 |
| 36 | maturation of SSU-rRNA (GO:0030490) | 3.32063005 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 3.31237105 |
| 38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.26134552 |
| 39 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.25956068 |
| 40 | defense response to protozoan (GO:0042832) | 3.20748628 |
| 41 | cellular protein complex disassembly (GO:0043624) | 3.19878148 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.17775754 |
| 43 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14830630 |
| 44 | B cell mediated immunity (GO:0019724) | 3.14370756 |
| 45 | cellular response to zinc ion (GO:0071294) | 3.14266501 |
| 46 | detection of bacterium (GO:0016045) | 3.14191917 |
| 47 | translational initiation (GO:0006413) | 3.10233794 |
| 48 | response to protozoan (GO:0001562) | 3.08088092 |
| 49 | myeloid dendritic cell activation (GO:0001773) | 3.04890636 |
| 50 | regulation of gamma-delta T cell activation (GO:0046643) | 3.04655872 |
| 51 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.04530018 |
| 52 | response to interferon-alpha (GO:0035455) | 3.02023005 |
| 53 | positive T cell selection (GO:0043368) | 3.00712119 |
| 54 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.97244468 |
| 55 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.96903872 |
| 56 | regulation of T cell tolerance induction (GO:0002664) | 2.96659142 |
| 57 | detection of other organism (GO:0098543) | 2.96294578 |
| 58 | regulation of B cell differentiation (GO:0045577) | 2.94525419 |
| 59 | thymic T cell selection (GO:0045061) | 2.94261650 |
| 60 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.94249901 |
| 61 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93013988 |
| 62 | negative thymic T cell selection (GO:0045060) | 2.92447134 |
| 63 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.89238200 |
| 64 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.89238200 |
| 65 | negative T cell selection (GO:0043383) | 2.86430829 |
| 66 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84597901 |
| 67 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84014896 |
| 68 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.82963328 |
| 69 | T cell selection (GO:0045058) | 2.82315566 |
| 70 | regulation of response to interferon-gamma (GO:0060330) | 2.82303498 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 2.82104631 |
| 72 | positive regulation of antigen processing and presentation (GO:0002579) | 2.80293059 |
| 73 | myeloid dendritic cell differentiation (GO:0043011) | 2.80034252 |
| 74 | protein complex disassembly (GO:0043241) | 2.79543918 |
| 75 | modulation by symbiont of host defense response (GO:0052031) | 2.79285497 |
| 76 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.79285497 |
| 77 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.79285497 |
| 78 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.79285497 |
| 79 | modulation by symbiont of host immune response (GO:0052553) | 2.79285497 |
| 80 | positive regulation by symbiont of host defense response (GO:0052509) | 2.79285497 |
| 81 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79145269 |
| 82 | T cell migration (GO:0072678) | 2.77589178 |
| 83 | negative regulation of interleukin-12 production (GO:0032695) | 2.74815086 |
| 84 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.74446265 |
| 85 | ribosomal large subunit biogenesis (GO:0042273) | 2.71645847 |
| 86 | positive regulation of cell killing (GO:0031343) | 2.70936732 |
| 87 | regulation of tolerance induction (GO:0002643) | 2.69313378 |
| 88 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.69059385 |
| 89 | regulation of interferon-alpha production (GO:0032647) | 2.68307035 |
| 90 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.66908456 |
| 91 | T cell costimulation (GO:0031295) | 2.66623152 |
| 92 | leukocyte aggregation (GO:0070486) | 2.66609443 |
| 93 | cellular response to interferon-gamma (GO:0071346) | 2.65967523 |
| 94 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.64320762 |
| 95 | positive regulation of granulocyte differentiation (GO:0030854) | 2.64108320 |
| 96 | lymphocyte costimulation (GO:0031294) | 2.63940346 |
| 97 | regulation of cell killing (GO:0031341) | 2.61825410 |
| 98 | T cell receptor signaling pathway (GO:0050852) | 2.60982914 |
| 99 | macromolecular complex disassembly (GO:0032984) | 2.60957244 |
| 100 | negative regulation of phagocytosis (GO:0050765) | 2.60196484 |
| 101 | mast cell activation (GO:0045576) | 2.59101550 |
| 102 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.58605705 |
| 103 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.58309809 |
| 104 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58247860 |
| 105 | negative regulation of innate immune response (GO:0045824) | 2.57562028 |
| 106 | response to peptidoglycan (GO:0032494) | 2.57554175 |
| 107 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.56349821 |
| 108 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.56159657 |
| 109 | response to interferon-gamma (GO:0034341) | 2.56139068 |
| 110 | interferon-gamma production (GO:0032609) | 2.55106457 |
| 111 | regulation of RIG-I signaling pathway (GO:0039535) | 2.54373152 |
| 112 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.54287772 |
| 113 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.53225442 |
| 114 | negative regulation of viral genome replication (GO:0045071) | 2.51856976 |
| 115 | regulation of necroptotic process (GO:0060544) | 2.51776122 |
| 116 | positive regulation of tolerance induction (GO:0002645) | 2.50944999 |
| 117 | lymphocyte migration (GO:0072676) | 2.50858898 |
| 118 | lymphocyte chemotaxis (GO:0048247) | 2.50647523 |
| 119 | neutrophil activation involved in immune response (GO:0002283) | 2.50622741 |
| 120 | positive thymic T cell selection (GO:0045059) | 2.50364355 |
| 121 | response to interleukin-15 (GO:0070672) | 2.50226178 |
| 122 | neutrophil activation (GO:0042119) | 2.50147217 |
| 123 | actin nucleation (GO:0045010) | 2.48928608 |
| 124 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.48884357 |
| 125 | cellular response to exogenous dsRNA (GO:0071360) | 2.48303508 |
| 126 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47407579 |
| 127 | DNA strand elongation (GO:0022616) | 2.46946479 |
| 128 | positive regulation of defense response to virus by host (GO:0002230) | 2.46920120 |
| 129 | positive regulation of T cell mediated immunity (GO:0002711) | 2.46918793 |
| 130 | regulation of antigen processing and presentation (GO:0002577) | 2.46205744 |
| 131 | sequestering of actin monomers (GO:0042989) | 2.45922673 |
| 132 | T cell homeostasis (GO:0043029) | 2.45858796 |
| 133 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.45715859 |
| 134 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.45605037 |
| 135 | telomere maintenance via recombination (GO:0000722) | 2.43755894 |
| 136 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.42103821 |
| 137 | protein targeting to membrane (GO:0006612) | 2.40698546 |
| 138 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.40165513 |
| 139 | T cell apoptotic process (GO:0070231) | 2.39840405 |
| 140 | mRNA catabolic process (GO:0006402) | 2.39334487 |
| 141 | formation of translation preinitiation complex (GO:0001731) | 2.38562178 |
| 142 | respiratory burst (GO:0045730) | 2.36918988 |
| 143 | B cell receptor signaling pathway (GO:0050853) | 2.36862268 |
| 144 | lymph node development (GO:0048535) | 2.35589202 |
| 145 | positive regulation of humoral immune response (GO:0002922) | 2.35172787 |
| 146 | natural killer cell activation (GO:0030101) | 2.34958070 |
| 147 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.34763945 |
| 148 | mature B cell differentiation involved in immune response (GO:0002313) | 2.34350028 |
| 149 | dendritic cell differentiation (GO:0097028) | 2.33803974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.71700279 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.67186236 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.58957952 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.12981364 |
| 5 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.03372008 |
| 6 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.90874238 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.66894593 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65641027 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.62352281 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.62253961 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.50905509 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.43497292 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.42710244 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.40532903 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.36909384 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.32475961 |
| 17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25485893 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.23190640 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20336412 |
| 20 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14781077 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.11596204 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.08733694 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06432865 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02996628 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02465131 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.90695127 |
| 27 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.89022726 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.88249179 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86975235 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84711637 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82579404 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81673442 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77361180 |
| 34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.74939769 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73393502 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71957525 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69824929 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.67788348 |
| 39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.67457294 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.67209686 |
| 41 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.66063864 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64165720 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.61908422 |
| 44 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.59534459 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58242090 |
| 46 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.57543513 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56558635 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54373600 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.54160402 |
| 50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49806067 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.49361367 |
| 52 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.49025560 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46337569 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.45885771 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44689029 |
| 56 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.44685063 |
| 57 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.42821462 |
| 58 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42067959 |
| 59 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.41485881 |
| 60 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.41078435 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38585046 |
| 62 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.37855487 |
| 63 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.37368873 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35008556 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34890844 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32061059 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31892610 |
| 68 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.31447027 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30595904 |
| 70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.30227201 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29385203 |
| 72 | * MAF_26560356_Chip-Seq_TH2_Human | 1.28606488 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28237537 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25530753 |
| 75 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24534939 |
| 76 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.24151797 |
| 77 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.23507615 |
| 78 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.23098218 |
| 79 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.21342913 |
| 80 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19593128 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18792051 |
| 82 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18077208 |
| 83 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16789726 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15292370 |
| 85 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.15285087 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14164937 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13898849 |
| 88 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.13072360 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12873207 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10155039 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09401973 |
| 92 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09038105 |
| 93 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.07860345 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07854954 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06854671 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05781840 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05641259 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05047766 |
| 99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05030717 |
| 100 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04783081 |
| 101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03603568 |
| 102 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03346882 |
| 103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02764724 |
| 104 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01852083 |
| 105 | P300_27268052_Chip-Seq_Bcells_Human | 1.01660500 |
| 106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00891096 |
| 107 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98835334 |
| 108 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.98691904 |
| 109 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.98667867 |
| 110 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97707528 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97298859 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96710965 |
| 113 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95970963 |
| 114 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95570893 |
| 115 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93558657 |
| 116 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90485864 |
| 117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90336227 |
| 118 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89800930 |
| 119 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.88701388 |
| 120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85214528 |
| 121 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.84681460 |
| 122 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.82380174 |
| 123 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.82171320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.45293905 |
| 2 | MP0000685_abnormal_immune_system | 3.36935979 |
| 3 | MP0009785_altered_susceptibility_to | 3.25965168 |
| 4 | MP0005671_abnormal_response_to | 3.20733411 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.88154652 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.73041863 |
| 7 | MP0003436_decreased_susceptibility_to | 2.69653444 |
| 8 | MP0001800_abnormal_humoral_immune | 2.69363312 |
| 9 | MP0005025_abnormal_response_to | 2.68830475 |
| 10 | MP0005387_immune_system_phenotype | 2.60060671 |
| 11 | MP0001790_abnormal_immune_system | 2.60060671 |
| 12 | MP0003724_increased_susceptibility_to | 2.58242771 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.56456829 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.55454173 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.42594439 |
| 16 | MP0002723_abnormal_immune_serum | 2.39696726 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.33192046 |
| 18 | MP0001819_abnormal_immune_cell | 2.33029016 |
| 19 | MP0002398_abnormal_bone_marrow | 2.20979191 |
| 20 | MP0001853_heart_inflammation | 2.20327636 |
| 21 | MP0002419_abnormal_innate_immunity | 2.15458916 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.15324619 |
| 23 | * MP0002166_altered_tumor_susceptibility | 2.10751453 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.03389835 |
| 25 | MP0000716_abnormal_immune_system | 2.01597686 |
| 26 | MP0002405_respiratory_system_inflammati | 1.93810516 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.92385443 |
| 28 | MP0001873_stomach_inflammation | 1.86450427 |
| 29 | MP0000689_abnormal_spleen_morphology | 1.85595701 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.83983020 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.83983020 |
| 32 | MP0002722_abnormal_immune_system | 1.82072211 |
| 33 | * MP0002006_tumorigenesis | 1.77979033 |
| 34 | MP0002429_abnormal_blood_cell | 1.77093679 |
| 35 | MP0006082_CNS_inflammation | 1.75405345 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.73687822 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.70637920 |
| 38 | MP0003693_abnormal_embryo_hatching | 1.65951978 |
| 39 | MP0000490_abnormal_crypts_of | 1.60212631 |
| 40 | MP0004510_myositis | 1.59507737 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.53879567 |
| 42 | MP0004947_skin_inflammation | 1.53199129 |
| 43 | MP0008469_abnormal_protein_level | 1.52842849 |
| 44 | MP0003866_abnormal_defecation | 1.52244999 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.48067235 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.47257519 |
| 47 | MP0003303_peritoneal_inflammation | 1.37066911 |
| 48 | MP0000858_altered_metastatic_potential | 1.34413441 |
| 49 | MP0005360_urolithiasis | 1.32657230 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.30816425 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.28617014 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.23634028 |
| 53 | MP0003186_abnormal_redox_activity | 1.22781379 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.20086498 |
| 55 | MP0003075_altered_response_to | 1.18681106 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 1.16404993 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.16370715 |
| 58 | MP0005166_decreased_susceptibility_to | 1.15976069 |
| 59 | MP0009764_decreased_sensitivity_to | 1.15327468 |
| 60 | MP0002019_abnormal_tumor_incidence | 1.13590490 |
| 61 | MP0005310_abnormal_salivary_gland | 1.10229532 |
| 62 | MP0010094_abnormal_chromosome_stability | 1.06154053 |
| 63 | MP0002132_abnormal_respiratory_system | 1.06116473 |
| 64 | MP0004957_abnormal_blastocyst_morpholog | 1.03364570 |
| 65 | MP0003448_altered_tumor_morphology | 1.03316518 |
| 66 | MP0003077_abnormal_cell_cycle | 1.02958282 |
| 67 | MP0000343_altered_response_to | 1.01927839 |
| 68 | MP0008057_abnormal_DNA_replication | 1.01809198 |
| 69 | MP0008007_abnormal_cellular_replicative | 1.01109924 |
| 70 | MP0003252_abnormal_bile_duct | 1.00139150 |
| 71 | MP0002933_joint_inflammation | 0.99410172 |
| 72 | MP0009278_abnormal_bone_marrow | 0.98535170 |
| 73 | MP0003183_abnormal_peptide_metabolism | 0.97583770 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96968576 |
| 75 | MP0005451_abnormal_body_composition | 0.96925881 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.95958179 |
| 77 | MP0009379_abnormal_foot_pigmentation | 0.94657293 |
| 78 | MP0009763_increased_sensitivity_to | 0.94286481 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 0.93781704 |
| 80 | MP0006054_spinal_hemorrhage | 0.90403472 |
| 81 | MP0008058_abnormal_DNA_repair | 0.88378605 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 0.88243523 |
| 83 | MP0009840_abnormal_foam_cell | 0.86494429 |
| 84 | MP0002163_abnormal_gland_morphology | 0.82103380 |
| 85 | MP0001666_abnormal_nutrient_absorption | 0.81480924 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.81230113 |
| 87 | MP0002095_abnormal_skin_pigmentation | 0.79352578 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.78612282 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.78453912 |
| 90 | MP0000609_abnormal_liver_physiology | 0.76754159 |
| 91 | MP0000313_abnormal_cell_death | 0.75825057 |
| 92 | MP0004381_abnormal_hair_follicle | 0.75801472 |
| 93 | MP0002254_reproductive_system_inflammat | 0.75332780 |
| 94 | MP0003828_pulmonary_edema | 0.74675746 |
| 95 | MP0001851_eye_inflammation | 0.74483857 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.73512277 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.72910916 |
| 98 | MP0000598_abnormal_liver_morphology | 0.71529985 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.70769012 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.70024217 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.69035807 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.67661203 |
| 103 | MP0001663_abnormal_digestive_system | 0.67396664 |
| 104 | MP0000372_irregular_coat_pigmentation | 0.67362665 |
| 105 | MP0010307_abnormal_tumor_latency | 0.67034869 |
| 106 | MP0001764_abnormal_homeostasis | 0.66354989 |
| 107 | MP0005165_increased_susceptibility_to | 0.64862041 |
| 108 | MP0000249_abnormal_blood_vessel | 0.64654527 |
| 109 | MP0009643_abnormal_urine_homeostasis | 0.64522143 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64424649 |
| 111 | MP0008873_increased_physiological_sensi | 0.64246514 |
| 112 | MP0003786_premature_aging | 0.63437431 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.63121825 |
| 114 | MP0000604_amyloidosis | 0.63017128 |
| 115 | MP0005390_skeleton_phenotype | 0.62293344 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.61952511 |
| 117 | MP0000477_abnormal_intestine_morphology | 0.61618126 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.61560866 |
| 119 | MP0005164_abnormal_response_to | 0.61207236 |
| 120 | MP0003806_abnormal_nucleotide_metabolis | 0.60788675 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.59578215 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.58580252 |
| 123 | MP0005023_abnormal_wound_healing | 0.57310260 |
| 124 | MP0003111_abnormal_nucleus_morphology | 0.57186797 |
| 125 | MP0003943_abnormal_hepatobiliary_system | 0.57142133 |
| 126 | MP0005365_abnormal_bile_salt | 0.56105036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.97416391 |
| 2 | Chronic otitis media (HP:0000389) | 4.51377334 |
| 3 | Thrombocytosis (HP:0001894) | 4.36100287 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.08530802 |
| 5 | Myositis (HP:0100614) | 4.07680992 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.00921245 |
| 7 | Recurrent bronchitis (HP:0002837) | 3.94081917 |
| 8 | IgM deficiency (HP:0002850) | 3.92716110 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.75243916 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.74712281 |
| 11 | Abnormal number of erythroid precursors (HP:0012131) | 3.61636215 |
| 12 | Recurrent viral infections (HP:0004429) | 3.55548720 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.53873778 |
| 14 | Nasal polyposis (HP:0100582) | 3.41559481 |
| 15 | Reticulocytopenia (HP:0001896) | 3.38772696 |
| 16 | Abnormality of the nasal mucosa (HP:0000433) | 3.32503937 |
| 17 | Abnormality of T cell physiology (HP:0011840) | 3.32273275 |
| 18 | Abnormality of T cells (HP:0002843) | 3.30667490 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.17011180 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.15709550 |
| 21 | Petechiae (HP:0000967) | 3.05748949 |
| 22 | Abnormality of T cell number (HP:0011839) | 3.05246765 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 2.95354561 |
| 24 | T lymphocytopenia (HP:0005403) | 2.93832784 |
| 25 | Pustule (HP:0200039) | 2.90905417 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 2.89955534 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.89955534 |
| 28 | Recurrent skin infections (HP:0001581) | 2.89760479 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 2.87937913 |
| 30 | Vasculitis (HP:0002633) | 2.84905883 |
| 31 | IgG deficiency (HP:0004315) | 2.83471455 |
| 32 | Orchitis (HP:0100796) | 2.81295165 |
| 33 | Meningitis (HP:0001287) | 2.81044884 |
| 34 | Interstitial pulmonary disease (HP:0006530) | 2.74019989 |
| 35 | Aplastic anemia (HP:0001915) | 2.72453908 |
| 36 | Agammaglobulinemia (HP:0004432) | 2.71586848 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.67787622 |
| 38 | Severe combined immunodeficiency (HP:0004430) | 2.67764748 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.63342319 |
| 40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.62063656 |
| 41 | Lymphopenia (HP:0001888) | 2.59949879 |
| 42 | Increased IgM level (HP:0003496) | 2.57993164 |
| 43 | Combined immunodeficiency (HP:0005387) | 2.57971526 |
| 44 | Pallor (HP:0000980) | 2.57327326 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.57034377 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.56476152 |
| 47 | Hypergammaglobulinemia (HP:0010702) | 2.54627929 |
| 48 | Inflammation of the large intestine (HP:0002037) | 2.51004237 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.50396771 |
| 50 | B lymphocytopenia (HP:0010976) | 2.50396771 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.50008702 |
| 52 | Retrobulbar optic neuritis (HP:0100654) | 2.49559314 |
| 53 | Optic neuritis (HP:0100653) | 2.49559314 |
| 54 | Chronic sinusitis (HP:0011109) | 2.44916787 |
| 55 | Cellulitis (HP:0100658) | 2.43274148 |
| 56 | Epistaxis (HP:0000421) | 2.41362849 |
| 57 | Prolonged bleeding time (HP:0003010) | 2.38141233 |
| 58 | Acute hepatic failure (HP:0006554) | 2.34632826 |
| 59 | Keratoconjunctivitis sicca (HP:0001097) | 2.34537853 |
| 60 | Obstructive lung disease (HP:0006536) | 2.32489714 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.32489714 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.32281239 |
| 63 | Lymphoma (HP:0002665) | 2.31702550 |
| 64 | Granulocytopenia (HP:0001913) | 2.31354990 |
| 65 | Periodontitis (HP:0000704) | 2.30800755 |
| 66 | Hypoproteinemia (HP:0003075) | 2.29874816 |
| 67 | Leukocytosis (HP:0001974) | 2.29449272 |
| 68 | Gingival bleeding (HP:0000225) | 2.28388331 |
| 69 | Poikiloderma (HP:0001029) | 2.27589055 |
| 70 | Colitis (HP:0002583) | 2.27474103 |
| 71 | Increased IgE level (HP:0003212) | 2.27302950 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.27131054 |
| 73 | Thyroiditis (HP:0100646) | 2.26835750 |
| 74 | Increased intramyocellular lipid droplets (HP:0012240) | 2.26815917 |
| 75 | Abnormality of eosinophils (HP:0001879) | 2.25888771 |
| 76 | Mitochondrial inheritance (HP:0001427) | 2.25886163 |
| 77 | Encephalitis (HP:0002383) | 2.25448921 |
| 78 | Purpura (HP:0000979) | 2.24317714 |
| 79 | Bronchitis (HP:0012387) | 2.23931271 |
| 80 | Hemoptysis (HP:0002105) | 2.23718341 |
| 81 | Eosinophilia (HP:0001880) | 2.22677406 |
| 82 | Macrocytic anemia (HP:0001972) | 2.22507161 |
| 83 | Microcytic anemia (HP:0001935) | 2.22274715 |
| 84 | Abnormality of the pleura (HP:0002103) | 2.22216674 |
| 85 | Chronic diarrhea (HP:0002028) | 2.21687160 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 2.20678288 |
| 87 | Gangrene (HP:0100758) | 2.19568551 |
| 88 | Hepatocellular necrosis (HP:0001404) | 2.17889507 |
| 89 | Reduced antithrombin III activity (HP:0001976) | 2.16631027 |
| 90 | Hepatic necrosis (HP:0002605) | 2.16330171 |
| 91 | Basal ganglia calcification (HP:0002135) | 2.15600832 |
| 92 | Increased muscle lipid content (HP:0009058) | 2.15445574 |
| 93 | Stomatitis (HP:0010280) | 2.11939555 |
| 94 | IgA deficiency (HP:0002720) | 2.11565259 |
| 95 | Anorexia (HP:0002039) | 2.10784489 |
| 96 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.09554317 |
| 97 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.09554317 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 2.08340975 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 2.07222817 |
| 100 | Urticaria (HP:0001025) | 2.07145664 |
| 101 | Increased serum ferritin (HP:0003281) | 2.05893059 |
| 102 | Pulmonary infiltrates (HP:0002113) | 2.05745213 |
| 103 | Arterial thrombosis (HP:0004420) | 2.05555214 |
| 104 | Joint swelling (HP:0001386) | 2.03710557 |
| 105 | Abnormality of the prostate (HP:0008775) | 2.02221954 |
| 106 | Pulmonary embolism (HP:0002204) | 2.01839379 |
| 107 | Skin ulcer (HP:0200042) | 2.01665342 |
| 108 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.01333024 |
| 109 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.99791737 |
| 110 | Abnormal platelet function (HP:0011869) | 1.99153594 |
| 111 | Impaired platelet aggregation (HP:0003540) | 1.99153594 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 1.98699887 |
| 113 | Verrucae (HP:0200043) | 1.97991883 |
| 114 | Papilloma (HP:0012740) | 1.97991883 |
| 115 | Neutropenia (HP:0001875) | 1.97444573 |
| 116 | Dicarboxylic aciduria (HP:0003215) | 1.96699274 |
| 117 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96699274 |
| 118 | Skin rash (HP:0000988) | 1.96151658 |
| 119 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95779873 |
| 120 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95779873 |
| 121 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95779873 |
| 122 | Gingivitis (HP:0000230) | 1.95434183 |
| 123 | Hepatosplenomegaly (HP:0001433) | 1.94323428 |
| 124 | Exertional dyspnea (HP:0002875) | 1.93295107 |
| 125 | Increased CSF lactate (HP:0002490) | 1.93010757 |
| 126 | Vacuolated lymphocytes (HP:0001922) | 1.92274238 |
| 127 | Pulmonary fibrosis (HP:0002206) | 1.90283306 |
| 128 | Amaurosis fugax (HP:0100576) | 1.89128187 |
| 129 | Chest pain (HP:0100749) | 1.88031562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.99389619 |
| 2 | VRK2 | 3.18302148 |
| 3 | NME2 | 3.06344142 |
| 4 | KIT | 2.69010315 |
| 5 | TYK2 | 2.60558139 |
| 6 | JAK3 | 2.58022766 |
| 7 | TBK1 | 2.56872709 |
| 8 | RIPK4 | 2.55529825 |
| 9 | TXK | 2.53468816 |
| 10 | ZAP70 | 2.37578861 |
| 11 | IKBKE | 2.35751375 |
| 12 | MAP3K14 | 2.35693476 |
| 13 | BLK | 2.29737924 |
| 14 | FLT3 | 2.22569090 |
| 15 | IRAK4 | 2.12268535 |
| 16 | TEC | 2.10220618 |
| 17 | PIM2 | 2.07707159 |
| 18 | BTK | 2.02062524 |
| 19 | KDR | 1.99910530 |
| 20 | IKBKB | 1.70357816 |
| 21 | FGFR4 | 1.67045626 |
| 22 | ERN1 | 1.65626427 |
| 23 | SYK | 1.61557462 |
| 24 | RPS6KA4 | 1.52916829 |
| 25 | TNK2 | 1.52840384 |
| 26 | TGFBR1 | 1.50403396 |
| 27 | CSF1R | 1.49226986 |
| 28 | LRRK2 | 1.46986569 |
| 29 | ACVR1B | 1.43921777 |
| 30 | MAP2K3 | 1.41269362 |
| 31 | JAK1 | 1.32834332 |
| 32 | BMPR2 | 1.32607526 |
| 33 | NLK | 1.29548195 |
| 34 | PKN2 | 1.29440167 |
| 35 | IRAK3 | 1.28470564 |
| 36 | STK16 | 1.24901032 |
| 37 | ITK | 1.24608747 |
| 38 | TAOK3 | 1.22642385 |
| 39 | EIF2AK1 | 1.19640436 |
| 40 | GRK6 | 1.17749364 |
| 41 | STK10 | 1.15881604 |
| 42 | LCK | 1.15061721 |
| 43 | TGFBR2 | 1.14976889 |
| 44 | EEF2K | 1.14827139 |
| 45 | PIM1 | 1.11036432 |
| 46 | CHUK | 1.05578487 |
| 47 | TESK2 | 1.05202876 |
| 48 | DAPK1 | 1.05010465 |
| 49 | LYN | 1.03835304 |
| 50 | BCKDK | 1.02851595 |
| 51 | MST4 | 0.99810748 |
| 52 | MAP3K12 | 0.99453366 |
| 53 | MAP3K10 | 0.97819248 |
| 54 | NEK9 | 0.97270816 |
| 55 | RPS6KB2 | 0.96804301 |
| 56 | PRKCQ | 0.95471148 |
| 57 | WEE1 | 0.94869428 |
| 58 | SMG1 | 0.92414045 |
| 59 | NUAK1 | 0.88624964 |
| 60 | CSK | 0.88222659 |
| 61 | MAP3K11 | 0.86985194 |
| 62 | FGFR3 | 0.86951643 |
| 63 | VRK1 | 0.85499680 |
| 64 | SCYL2 | 0.83224565 |
| 65 | MYLK | 0.80551308 |
| 66 | GRK7 | 0.80428469 |
| 67 | HCK | 0.79534370 |
| 68 | EIF2AK3 | 0.79399458 |
| 69 | MATK | 0.77258136 |
| 70 | STK4 | 0.75520895 |
| 71 | CDK4 | 0.75354571 |
| 72 | STK24 | 0.71113653 |
| 73 | JAK2 | 0.66714586 |
| 74 | PASK | 0.65418629 |
| 75 | TAOK2 | 0.64526327 |
| 76 | HIPK2 | 0.62764670 |
| 77 | DYRK3 | 0.61876743 |
| 78 | MAP3K1 | 0.60224053 |
| 79 | ATR | 0.60039096 |
| 80 | CDC7 | 0.59985396 |
| 81 | MAP3K13 | 0.59852843 |
| 82 | MAP2K2 | 0.59334604 |
| 83 | NEK2 | 0.58061383 |
| 84 | MAPKAPK3 | 0.57821450 |
| 85 | ILK | 0.57665852 |
| 86 | MAP3K3 | 0.56667374 |
| 87 | MAPK11 | 0.55389406 |
| 88 | TIE1 | 0.55207715 |
| 89 | EPHB1 | 0.55202069 |
| 90 | MAP2K6 | 0.55099812 |
| 91 | BUB1 | 0.54434080 |
| 92 | SIK3 | 0.53495515 |
| 93 | EIF2AK2 | 0.51560735 |
| 94 | TAF1 | 0.51436497 |
| 95 | LIMK1 | 0.51268238 |
| 96 | TRIB3 | 0.50043397 |
| 97 | TLK1 | 0.49512142 |
| 98 | PDK1 | 0.49104662 |
| 99 | AURKB | 0.48644817 |
| 100 | RPS6KA6 | 0.47709474 |
| 101 | CDK7 | 0.46522739 |
| 102 | PRPF4B | 0.46397337 |
| 103 | PAK4 | 0.45635234 |
| 104 | MAP4K2 | 0.45291896 |
| 105 | PRKG2 | 0.44587630 |
| 106 | ADRBK2 | 0.44518471 |
| 107 | MAP3K5 | 0.43668106 |
| 108 | TSSK6 | 0.42540532 |
| 109 | MARK3 | 0.41881881 |
| 110 | TESK1 | 0.41841205 |
| 111 | CLK1 | 0.40083336 |
| 112 | DAPK3 | 0.39909771 |
| 113 | MAPKAPK2 | 0.39806588 |
| 114 | FES | 0.39164561 |
| 115 | MAP3K8 | 0.39075862 |
| 116 | BRSK2 | 0.38708609 |
| 117 | TAOK1 | 0.37798196 |
| 118 | PIK3CG | 0.37760383 |
| 119 | MAPK4 | 0.37146579 |
| 120 | RPS6KA5 | 0.36913123 |
| 121 | GRK5 | 0.36805665 |
| 122 | PRKCD | 0.36721558 |
| 123 | CDK6 | 0.36517839 |
| 124 | EPHA3 | 0.35833540 |
| 125 | PIK3CA | 0.34082358 |
| 126 | RPS6KC1 | 0.33829892 |
| 127 | CDK19 | 0.33481096 |
| 128 | FYN | 0.33007226 |
| 129 | IRAK1 | 0.32063395 |
| 130 | FGR | 0.31340069 |
| 131 | ZAK | 0.30699772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.79193066 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.20173172 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.07236785 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.63982919 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.24760257 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.20800741 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20121664 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.17388011 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.14157853 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.10047900 |
| 11 | * Proteasome_Homo sapiens_hsa03050 | 2.04919918 |
| 12 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 1.99920127 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.98686691 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89747150 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.86069958 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.83847130 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73380047 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.63795608 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60396854 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.59780773 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.55812701 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53250340 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43035521 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.42851439 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40728675 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.37601338 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34462241 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.32793975 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31032206 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30992475 |
| 31 | Spliceosome_Homo sapiens_hsa03040 | 1.28772941 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27983486 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.27768382 |
| 34 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.26116623 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.18025368 |
| 36 | RNA polymerase_Homo sapiens_hsa03020 | 1.15254858 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14709641 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12556294 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.09808685 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.08170251 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07088467 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.05968607 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.05109012 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.04638129 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04238762 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03176871 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02834900 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00628551 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00168147 |
| 50 | Malaria_Homo sapiens_hsa05144 | 0.98347584 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95179089 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94802394 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94134041 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92553248 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91941479 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.89959606 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87687975 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86575101 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.85114084 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82919614 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82027702 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81824812 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79425978 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79374160 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77959641 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77467569 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74958209 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74606348 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.70031669 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69875753 |
| 71 | Protein export_Homo sapiens_hsa03060 | 0.69460547 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.69244142 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68234935 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.66828360 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65694155 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65663274 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.64463190 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60398912 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60365611 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60235432 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59676623 |
| 82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59209564 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58444653 |
| 84 | RNA transport_Homo sapiens_hsa03013 | 0.58102370 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57876752 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57634367 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56936176 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56685560 |
| 89 | Cell cycle_Homo sapiens_hsa04110 | 0.56578161 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.54205655 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52562970 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52092371 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48672539 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48652219 |
| 95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47703804 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47639520 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47392457 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46225302 |
| 99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46219452 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.46016362 |
| 101 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.45832765 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44725998 |
| 103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44658048 |
| 104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44565835 |
| 105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43598255 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.42928979 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41378261 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40814013 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40608266 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40339680 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39308650 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38718079 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37592837 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36817222 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36771962 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35770253 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34707170 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33712131 |
| 119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33633505 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32341357 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31844088 |
| 122 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.31778277 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.29789088 |
| 124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28336210 |
| 125 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.28327152 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26793551 |
| 127 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.26306361 |

